This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Arcadia Biosciences to Merge With Roosevelt, Shares Surge 105%
by Zacks Equity Research
RKDA inks deal with Roosevelt to become a new entity, Roosevelt Resources, with Roosevelt as the majority shareholder.
SSRM to Boost Portfolio With Cripple Creek & Victor Gold Mine Buyout
by Zacks Equity Research
SSR Mining inks deal with Newmont to acquire Cripple Creek & Victor Gold mine.
WPM Expands Portfolio With Gold Stream Acquisition of Kurmuk Project
by Zacks Equity Research
Wheaton Precious Metals and its subsidiary sign a streaming agreement with Allied to move forward with the construction of the Kurmuk project.
International Flavors (IFF) Up 2% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
International Flavors (IFF) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Here's Why You Should Retain Mosaic Stock in Your Portfolio
by Zacks Equity Research
MOS benefits from healthy demand for phosphate and potash on the back of favorable agricultural market fundamentals amid pricing pressure.
Why Is Celanese (CE) Down 20.3% Since Last Earnings Report?
by Zacks Equity Research
Celanese (CE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Rio Tinto and Sumitomo Metal Mining to Jointly Develop Winu Project
by Zacks Equity Research
RIO signs a joint venture deal with Sumitomo Metal Mining to develop the Winu copper-gold project located in Western Australia.
Here's Why You Should Hold Onto Air Products Stock for Now
by Zacks Equity Research
While the softness in China is a concern, APD gains on its investments in high-return industrial gas projects and productivity measures.
B2Gold Maintains Operations at Fekola Mine Amid a Labor Strike
by Zacks Equity Research
BTG continues to expect 2024 annual gold production guidance for the Fekola mine to be at the lower end of the 420,000-450,000 ounces despite a labor strike.
CF Industries' Stock Up 14% in 3 Months: What's Driving the Rise?
by Zacks Equity Research
CF gains on healthy global demand for nitrogen fertilizers backed by supportive agricultural fundamentals and lower natural gas costs.
Here's Why You Should Hold Onto Eastman Chemical Stock for Now
by Zacks Equity Research
While EMN faces headwinds from weak demand and inventory de-stocking in certain markets, it benefits from cost management, pricing actions and innovation.
Air Products Stock Up 22% in 3 Months: What's Driving the Rally?
by Zacks Equity Research
APD benefits from its investments in high-return industrial gas projects and productivity and pricing measures.
Denison Mines Enters Deal to Form 3 Uranium Joint Ventures With Cosa
by Zacks Equity Research
DNN signs a deal to develop three uranium exploration joint ventures in the eastern part of the Athabasca Basin in northern Saskatchewan.
Why Is Ingevity (NGVT) Up 14.6% Since Last Earnings Report?
by Zacks Equity Research
Ingevity (NGVT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Here's Why You Should Add DuPont Stock to Your Portfolio Now
by Zacks Equity Research
DD gains on its focus on growth through innovation and acquisition as well as productivity improvement actions.
Air Products Shares Scale 52-Week High: What's Driving the Stock?
by Zacks Equity Research
APD gains on its investments in high-return industrial gas projects and productivity and cost improvement actions.
Endeavour Silver to Raise $73 Million to Develop Pitarrilla Project
by Zacks Equity Research
EXK signs a deal to sell 15,825,000 common shares for $4.60 per share to raise $73 million toward the advancement of its Pitarrilla project.
CF Industries Shares Scale 52-Week High: What's Driving the Stock?
by Zacks Equity Research
CF benefits from healthy global demand for nitrogen fertilizers backed by supportive agricultural fundamentals and lower natural gas costs.
Here's What Makes CF Industries Stock a Solid Choice Right Now
by Zacks Equity Research
CF presents a compelling investment case backed by favorable nitrogen demand fundamentals, rising earnings estimates and an attractive valuation.
Should Value Investors Buy Ingevity (NGVT) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Ingevity's Earnings Beat Estimates in Q3, Revenues Down Y/Y
by Zacks Equity Research
The downside in NGVT's Q3 sales is attributable to the repositioning of the Performance Chemicals segment.
Ingevity (NGVT) Soars 12.0%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Ingevity (NGVT) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Ingevity to Launch Capa HS at the 2024 Polyurethanes Conference
by Zacks Equity Research
The Capa HS series is the latest example of NGVT's current innovation push, which is extending the performance boundaries of Caprolactone technology.
Why Is Ingevity (NGVT) Down 7.4% Since Last Earnings Report?
by Zacks Equity Research
Ingevity (NGVT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Flexible Solutions (FSI) Q2 Earnings & Sales Top Estimates
by Zacks Equity Research
Flexible Solutions' (FSI) Biodegradable Polymers sales rise in Q2 on higher customer orders.